spacer
home > > Summer 2015
PUBLICATIONS

Summer 2015

   
Text
PDF
   
spacer
News and Press Releases

Sensitech Inc. Marks 30th Anniversary and Introduces New SensiWatchTM Platform for End-to-End Real-Time In-Transit Visibility

Beverly, MA, June 22, 2020 – For 30 years, Sensitech Inc. has helped leading companies in the food, pharmaceutical, industrial and consumer goods segmentsdeliver higher-quality products, ensure consumer safety, comply with rigorous regulatory requirements, protect brand equity, and increase profitability. Today,Sensitech builds on this legacy with the announcement of a new state-of-the-art, end-to-end,real-time in-transit visibility solution –the SensiWatchTMPlatform.Sensitech is part of Carrier Global Corporation (NYSE: CARR), a leading global provider of innovative heating, ventilating and air conditioning (HVAC), refrigeration, fire, security and building automation technologies.
More info >>

White Papers

The Rare Disease Patients Experience

When planning a clinical trial for a rare disease, it is important to have a holistic understanding of your patient population. You want to be aware of where your patients are coming from, and what it is like to walk in their shoes. These patients need your trial just as much as you need them; even from the earliest stages, conceptualize your rare disease trial as an altruistic relationship between the patient population and your study.
More info >>

Industry Events

Clinical Operations in Oncology Trials West Coast

17-18 November 2020, Hilton San Francisco Airport Bayfront

Clinical Operations in Oncology Trials West Coast will be returning this April for another 2 day event full of thought-provoking presentations, discussions and roundtables. This years' conference highlights include the high-level, interactive immuno-oncology discussion panel where specialists from Shasta Bio Ventures, Abbvie and BeiGene shared their top tips on how to run successful and impactful immuno-oncology studies.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement